HB 466 — Delaware
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.
Delaware legislative agenda & upcoming votes Delaware session calendar
Summary
This Act adds authority and guidelines for access to and use of intranasal epinephrine nasal sprays at institutions of higher education to the existing framework for access to and use of epinephrine injectors. This Act also removes the requirement of the Department of Public Health from filing an annual report regarding the use of epinephrine autoinjectors for the prior academic year with the General Assembly under this section.
- HB 466 is a bill in the Delaware House, 153 session, introduced June 4, 2026.
- Sponsored by DeShanna U Neal and David P. Sokola, with 1 cosponsor.
- Current status: signed into law.
- Most recent action (July 23, 2026): Signed by Governor.
- 2 recorded votes; the most recent, on June 30, 2026, passed 21-0.
-
State Representative, District 13
Democratic -
State Senator, District 8
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: DeShanna U Neal, David P. Sokola
Cosponsors (1): Kendra Johnson
History
- Introduced, completed
- Passed House, completed
- Passed Senate, completed
- Sent to Governor, completed
- Signed into law, completed, current stage
- House Introduced and Assigned to Health & Human Development Committee in House Milestone
- House Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 10 On Its Merits
-
House
Passed By House. Votes: 38 YES 1 NO 2 ABSENT
Milestone
Passage: 38 yes 1 no, 2 other Passed, 97% yes
- Senate Assigned to Health & Social Services Committee in Senate Milestone
- Senate Reported Out of Committee (Health & Social Services) in Senate with 6 On Its Merits
-
Senate
Passed By Senate. Votes: 21 YES
Milestone
Passage: 21 yes 0 no Passed, 100% yes
- Governor Signed by Governor Milestone Latest